Aspira Pathlab (540788)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹31 |
| Market Cap | ₹31.96 Cr |
| P/E Ratio | 39.91 |
| ROCE | 17.37% |
| ROE | 13.19% |
| Dividend Yield | 0% |
| Profit Growth | -510.53% |
| Debt/Equity | — |
| Sales Growth | -5.36% |
| 52-Week Range | ₹49 — ₹119 |
| Sector | Healthcare Services |
| Book Value | ₹9.84 |
Aspira Pathlab trades with a P/E ratio of 39.91, ROCE of 17.37%, ROE of 13.19%, profit growth of -510.53%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer